Westlake Chemical (WLK) Getting Somewhat Favorable Press Coverage, Study Finds

News articles about Westlake Chemical (NYSE:WLK) have been trending somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Westlake Chemical earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned news articles about the specialty chemicals company an impact score of 45.4892268101474 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the headlines that may have effected Accern’s rankings:

How to Become a New Pot Stock Millionaire

Shares of Westlake Chemical stock traded down $2.90 on Friday, reaching $109.95. The company had a trading volume of 1,027,468 shares, compared to its average volume of 797,905. The company has a market capitalization of $14,834.10, a price-to-earnings ratio of 20.10, a price-to-earnings-growth ratio of 1.11 and a beta of 1.53. Westlake Chemical has a 52-week low of $59.58 and a 52-week high of $121.30. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.30 and a current ratio of 1.76.

Westlake Chemical (NYSE:WLK) last released its quarterly earnings results on Tuesday, February 20th. The specialty chemicals company reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.07). The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $2.06 billion. Westlake Chemical had a net margin of 16.22% and a return on equity of 16.48%. Westlake Chemical’s revenue was up 15.9% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share. equities analysts expect that Westlake Chemical will post 8.48 earnings per share for the current year.

A number of equities analysts have commented on the stock. Royal Bank of Canada reaffirmed a “buy” rating and set a $130.00 target price on shares of Westlake Chemical in a research note on Tuesday. JPMorgan Chase downgraded shares of Westlake Chemical from an “overweight” rating to a “neutral” rating and set a $110.00 target price on the stock. in a research note on Monday, April 9th. BMO Capital Markets assumed coverage on shares of Westlake Chemical in a research note on Tuesday, March 27th. They set a “market perform” rating and a $125.00 target price on the stock. Zacks Investment Research downgraded shares of Westlake Chemical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 14th. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $121.00 target price on shares of Westlake Chemical in a research note on Friday, February 23rd. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $113.80.

In other news, EVP Robert F. Buesinger sold 19,349 shares of the business’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $113.04, for a total value of $2,187,210.96. Following the sale, the executive vice president now directly owns 14,731 shares of the company’s stock, valued at approximately $1,665,192.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert T. Blakely sold 4,038 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $111.00, for a total transaction of $448,218.00. Following the completion of the sale, the director now directly owns 7,662 shares in the company, valued at $850,482. The disclosure for this sale can be found here. Insiders sold a total of 103,080 shares of company stock worth $11,545,548 over the last three months. Insiders own 72.00% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/20/westlake-chemical-wlk-getting-somewhat-favorable-press-coverage-study-finds.html.

Westlake Chemical Company Profile

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Insider Buying and Selling by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply